Search results for: 'CHINA pharmaceutical market'

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

This study aims to evaluate commercial aircraft fleet and the MRO market in China, consisting of the current fleet in 2018 and segmented on multiple criteria. It further focuses on the market trends, technology Mega Trends, and opportunity areas. Among all the Northeast Asian nations, China is the major MRO spender in terms of MRO market size. This...

29 Jan 2020  |  Asia Pacific  |  Market Research

APAC Privileged Access Management (PAM) Solutions Market, Forecast to 2023

Regulatory Needs Drive Overall Market Growth in Asia-Pacific and China

Infographics

×

Privileged Access Management (PAM) has been gaining strong traction in the Asia-Pacific (APAC) region due to the growing stringency of regulations governing regulated industries such as banking, financial services, and insurance (BFSI), government, and service providers. PAM plays a key role in cyber security today. With data privacy and personal d...

11 Feb 2020  |  Asia Pacific  |  Market Research

Commercial MRO Market in Japan, S. Korea, and China, 2019

Commercial MRO Market Spending Hovers Around USD 13.0 Billion among Top-3 Nations of NE Asia in 2019

Infographics

×

This study aims to evaluate the commercial aircraft fleet and spending on MRO services among the top 3 Northeast Asian nations consisting of China, South Korea, and Japan boasting a combined airline fleet size of close to 5,000 aircraft at the end of 2019. The study focuses on the fleet and MRO spending comparisons among these top 3 N.E. Asian nati...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...

28 Aug 2020  |  Global  |  Technology Research

Data Science Impacting the Pharmaceutical Industry

Part I: Drug Discovery Applications

Infographics

×

Data science and AI have the potential to transform drug discovery in terms of costs, speed and efficiency. With explosion in biomedical data, data sharing and analysis platforms have surged. AI technologies are moving to the next phase of advancements, and when combined with other emerging tech areas, AI is expected to witness a full fledged adopt...

27 Jul 2022  |  Asia Pacific  |  Market Research

China Facility Management Growth Opportunities

Sustainability Innovation Culture and Technologies to Support Facility Management Value Proposition

Infographics

×

The Chinese facility management (FM) market is at a fast-growing stage, owing to the slower start than other Asia-Pacific developing markets. It has been enjoying double-digit growth since before COVID-19. The rapidly increasing outsourcing culture in the country has driven FM market development, supported by a large and still expanding asset base....

13 Sep 2021  |  North America  |  Market Research

Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities

Emerging Pharmaceuticals and Highly Potent Complex Molecules Creating Future Growth Potential

Infographics

×

This study presents Frost & Sullivan’s overall market and segment-wise revenue forecasts of the global small molecule contract development and manufacturing organization (CDMO) industry. It highlights key growth opportunities for small molecule CDMOs based on the main evolution in their business models and strategic approaches as well as those of p...